-
1
-
-
32544441379
-
The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells
-
Aguado T, Palazuelos J, Monory K, Stella N, Cravatt B, Lutz B, et al. The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J Neurosci 2006; 26: 155161.
-
(2006)
J Neurosci
, vol.26
, pp. 155161
-
-
Aguado, T.1
Palazuelos, J.2
Monory, K.3
Stella, N.4
Cravatt, B.5
Lutz, B.6
-
2
-
-
33847420442
-
Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis
-
Benito C, Romero JP, Tolon RM, Clemente D, Docagne F, Hillard CJ, et al. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci 2007; 27: 2396402.
-
(2007)
J Neurosci
, vol.27
, pp. 2396402
-
-
Benito, C.1
Romero, J.P.2
Tolon, R.M.3
Clemente, D.4
Docagne, F.5
Hillard, C.J.6
-
3
-
-
49249089029
-
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
-
Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. J Exp Med 2008; 205: 186977.
-
(2008)
J Exp Med
, vol.205
, pp. 186977
-
-
Bjorkqvist, M.1
Wild, E.J.2
Thiele, J.3
Silvestroni, A.4
Andre, R.5
Lahiri, N.6
-
4
-
-
33845768784
-
Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms
-
Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007; 8: 5769.
-
(2007)
Nat Rev Neurosci
, vol.8
, pp. 5769
-
-
Block, M.L.1
Zecca, L.2
Hong, J.S.3
-
5
-
-
0034685707
-
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor
-
Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder CC, et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol 2000; 396: 1419.
-
(2000)
Eur J Pharmacol
, vol.396
, pp. 1419
-
-
Buckley, N.E.1
McCoy, K.L.2
Mezey, E.3
Bonner, T.4
Zimmer, A.5
Felder, C.C.6
-
6
-
-
4444350918
-
Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephaliner-gic neuronal degeneration in Huntington's disease
-
Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT, et al. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephaliner-gic neuronal degeneration in Huntington's disease. J Neurosci 2004; 24: 772739.
-
(2004)
J Neurosci
, vol.24
, pp. 772739
-
-
Canals, J.M.1
Pineda, J.R.2
Torres-Peraza, J.F.3
Bosch, M.4
Martin-Ibanez, R.5
Munoz, M.T.6
-
7
-
-
28644433087
-
Normal huntingtin function: An alternative approach to Huntington's disease
-
Cattaneo E, Zuccato C, Tartari M. Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci 2005; 6: 91930.
-
(2005)
Nat Rev Neurosci
, vol.6
, pp. 91930
-
-
Cattaneo, E.1
Zuccato, C.2
Tartari, M.3
-
8
-
-
34848897836
-
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis
-
Centonze D, Bari M, Rossi S, Prosperetti C, Furlan R, Fezza F, et al. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain 2007; 130: 254353.
-
(2007)
Brain
, vol.130
, pp. 254353
-
-
Centonze, D.1
Bari, M.2
Rossi, S.3
Prosperetti, C.4
Furlan, R.5
Fezza, F.6
-
9
-
-
20444367602
-
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice
-
Centonze D, Rossi S, Prosperetti C, Tscherter A, Bernardi G, Maccarrone M, et al. Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. Biol Psychiatry 2005; 57: 15839.
-
(2005)
Biol Psychiatry
, vol.57
, pp. 15839
-
-
Centonze, D.1
Rossi, S.2
Prosperetti, C.3
Tscherter, A.4
Bernardi, G.5
MacCarrone, M.6
-
10
-
-
0037322570
-
Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease
-
Cepeda C, Hurst RS, Calvert CR, Hernandez-Echeagaray E, Nguyen OK, Jocoy E, et al. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J Neurosci 2003; 23: 9619.
-
(2003)
J Neurosci
, vol.23
, pp. 9619
-
-
Cepeda, C.1
Hurst, R.S.2
Calvert, C.R.3
Hernandez-Echeagaray, E.4
Nguyen, O.K.5
Jocoy, E.6
-
11
-
-
0033912716
-
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
-
Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, et al. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 2000; 6: 797801.
-
(2000)
Nat Med
, vol.6
, pp. 797801
-
-
Chen, M.1
Ona, V.O.2
Li, M.3
Ferrante, R.J.4
Fink, K.B.5
Zhu, S.6
-
12
-
-
41549117229
-
Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5/RANTES) by astrocytes
-
Chou SY, Weng JY, Lai HL, Liao F, Sun SH, Tu PH, et al. Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5/RANTES) by astrocytes. J Neurosci 2008; 28: 327790.
-
(2008)
J Neurosci
, vol.28
, pp. 327790
-
-
Chou, S.Y.1
Weng, J.Y.2
Lai, H.L.3
Liao, F.4
Sun, S.H.5
Tu, P.H.6
-
13
-
-
33947583201
-
Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation
-
Docagne F, Muneton V, Clemente D, Ali C, Loria F, Correa F, et al. Excitotoxicity in a chronic model of multiple sclerosis: neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation. Mol Cell Neurosci 2007; 34: 55161.
-
(2007)
Mol Cell Neurosci
, vol.34
, pp. 55161
-
-
Docagne, F.1
Muneton, V.2
Clemente, D.3
Ali, C.4
Loria, F.5
Correa, F.6
-
14
-
-
29544446576
-
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells
-
Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S, et al. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 2006; 49: 6779.
-
(2006)
Neuron
, vol.49
, pp. 6779
-
-
Eljaschewitsch, E.1
Witting, A.2
Mawrin, C.3
Lee, T.4
Schmidt, P.M.5
Wolf, S.6
-
15
-
-
33845959991
-
Cannabinoid CB2 receptor: A new target for controlling neural cell survival?
-
Fernandez-Ruiz J, Romero J, Velasco G, Tolon RM, Ramos JA, Guzman M. Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends Pharmacol Sci 2007; 28: 3945.
-
(2007)
Trends Pharmacol Sci
, vol.28
, pp. 3945
-
-
Fernandez-Ruiz, J.1
Romero, J.2
Velasco, G.3
Tolon, R.M.4
Ramos, J.A.5
Guzman, M.6
-
16
-
-
57449098411
-
The endocannabinoid system is modulated in response to spinal cord injury in rats
-
Garcia-Ovejero D, Arevalo-Martin A, Petrosino S, Docagne F, Hagen C, Bisogno T, et al. The endocannabinoid system is modulated in response to spinal cord injury in rats. Neurobiol Dis 2009; 33: 5771.
-
(2009)
Neurobiol Dis
, vol.33
, pp. 5771
-
-
Garcia-Ovejero, D.1
Arevalo-Martin, A.2
Petrosino, S.3
Docagne, F.4
Hagen, C.5
Bisogno, T.6
-
17
-
-
45149107487
-
Mechanisms of neurodegeneration in Huntington's disease
-
Gil JM, Rego AC. Mechanisms of neurodegeneration in Huntington's disease. Eur J Neurosci 2008; 27: 280320.
-
(2008)
Eur J Neurosci
, vol.27
, pp. 280320
-
-
Gil, J.M.1
Rego, A.C.2
-
18
-
-
0034081681
-
The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease
-
Glass M, Dragunow M, Faull RL. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience 2000; 97: 50519.
-
(2000)
Neuroscience
, vol.97
, pp. 50519
-
-
Glass, M.1
Dragunow, M.2
Faull, R.L.3
-
19
-
-
12944263838
-
HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor
-
Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, et al. HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor. Proc Natl Acad Sci USA 1999; 96: 1422833.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 1422833
-
-
Hanus, L.1
Breuer, A.2
Tchilibon, S.3
Shiloah, S.4
Goldenberg, D.5
Horowitz, M.6
-
20
-
-
46849097142
-
NMDA receptors in clinical neurology: Excitatory times ahead
-
Kalia LV, Kalia SK, Salter MW. NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol 2008; 7: 74255.
-
(2008)
Lancet Neurol
, vol.7
, pp. 74255
-
-
Kalia, L.V.1
Kalia, S.K.2
Salter, M.W.3
-
21
-
-
51349141952
-
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
-
Katona I, Freund TF. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 2008; 14: 92330.
-
(2008)
Nat Med
, vol.14
, pp. 92330
-
-
Katona, I.1
Freund, T.F.2
-
22
-
-
33846908287
-
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models
-
Kreitzer AC, Malenka RC. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 2007; 445: 6437.
-
(2007)
Nature
, vol.445
, pp. 6437
-
-
Kreitzer, A.C.1
Malenka, R.C.2
-
23
-
-
0037040530
-
Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB(1) receptors in the basal ganglia of a transgenic model of Huntington's disease
-
Lastres-Becker I, Berrendero F, Lucas JJ, Martin-Aparicio E, Yamamoto A, Ramos JA, et al. Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB(1) receptors in the basal ganglia of a transgenic model of Huntington's disease. Brain Res 2002; 929: 23642.
-
(2002)
Brain Res
, vol.929
, pp. 23642
-
-
Lastres-Becker, I.1
Berrendero, F.2
Lucas, J.J.3
Martin-Aparicio, E.4
Yamamoto, A.5
Ramos, J.A.6
-
24
-
-
43449086380
-
Selective ablation of proliferating astrocytes does not affect disease outcome in either acute or chronic models of motor neuron degeneration
-
Lepore AC, Dejea C, Carmen J, Rauck B, Kerr DA, Sofroniew MV, et al. Selective ablation of proliferating astrocytes does not affect disease outcome in either acute or chronic models of motor neuron degeneration. Exp Neurol 2008; 211: 42332.
-
(2008)
Exp Neurol
, vol.211
, pp. 42332
-
-
Lepore, A.C.1
Dejea, C.2
Carmen, J.3
Rauck, B.4
Kerr, D.A.5
Sofroniew, M.V.6
-
25
-
-
35549006420
-
Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease
-
Lobsiger CS, Cleveland DW. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 2007; 10: 135560.
-
(2007)
Nat Neurosci
, vol.10
, pp. 135560
-
-
Lobsiger, C.S.1
Cleveland, D.W.2
-
26
-
-
34047139505
-
The endocannabinoid pathway in Huntington's disease: A comparison with other neurodegenerative diseases
-
Maccarrone M, Battista N, Centonze D. The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases. Prog Neurobiol 2007; 81: 34979.
-
(2007)
Prog Neurobiol
, vol.81
, pp. 34979
-
-
MacCarrone, M.1
Battista, N.2
Centonze, D.3
-
27
-
-
33144480327
-
Cannabinoid receptors as therapeutic targets
-
Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 2006; 46: 10122.
-
(2006)
Annu Rev Pharmacol Toxicol
, vol.46
, pp. 10122
-
-
MacKie, K.1
-
28
-
-
16044373842
-
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
-
Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87: 493506.
-
(1996)
Cell
, vol.87
, pp. 493506
-
-
Mangiarini, L.1
Sathasivam, K.2
Seller, M.3
Cozens, B.4
Harper, A.5
Hetherington, C.6
-
29
-
-
26844448746
-
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
-
Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem 2005; 95: 43745.
-
(2005)
J Neurochem
, vol.95
, pp. 43745
-
-
Maresz, K.1
Carrier, E.J.2
Ponomarev, E.D.3
Hillard, C.J.4
Dittel, B.N.5
-
30
-
-
34147165471
-
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB(1) on neurons and CB(2) on auto-reactive T cells
-
Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, et al. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB(1) on neurons and CB(2) on auto-reactive T cells. Nat Med 2007; 13: 4927.
-
(2007)
Nat Med
, vol.13
, pp. 4927
-
-
Maresz, K.1
Pryce, G.2
Ponomarev, E.D.3
Marsicano, G.4
Croxford, J.L.5
Shriver, L.P.6
Al, E.7
-
31
-
-
11244306357
-
Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice
-
McCaw EA, Hu H, Gomez GT, Hebb AL, Kelly ME, Denovan-Wright EM. Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice. Eur J Biochem 2004; 271: 490920.
-
(2004)
Eur J Biochem
, vol.271
, pp. 490920
-
-
McCaw, E.A.1
Hu, H.2
Gomez, G.T.3
Hebb, A.L.4
Kelly, M.E.5
Denovan-Wright, E.M.6
-
32
-
-
38349086382
-
CB2 receptor-mediated migration of immune cells: It can go either way
-
Miller AM, Stella N. CB2 receptor-mediated migration of immune cells: it can go either way. Br J Pharmacol 2008; 153: 299308.
-
(2008)
Br J Pharmacol
, vol.153
, pp. 299308
-
-
Miller, A.M.1
Stella, N.2
-
33
-
-
33749508895
-
Essential protective roles of reactive astrocytes in traumatic brain injury
-
Myer DJ, Gurkoff GG, Lee SM, Hovda DA, Sofroniew MV. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 2006; 129: 276172.
-
(2006)
Brain
, vol.129
, pp. 276172
-
-
Myer, D.J.1
Gurkoff, G.G.2
Lee, S.M.3
Hovda, D.A.4
Sofroniew, M.V.5
-
34
-
-
40849100074
-
Endocannabinoids mediate neuron-astrocyte communication
-
Navarrete M, Araque A. Endocannabinoids mediate neuron-astrocyte communication. Neuron 2008; 57: 88393.
-
(2008)
Neuron
, vol.57
, pp. 88393
-
-
Navarrete, M.1
Araque, A.2
-
35
-
-
33745919498
-
Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury
-
Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 2006; 12: 82934.
-
(2006)
Nat Med
, vol.12
, pp. 82934
-
-
Okada, S.1
Nakamura, M.2
Katoh, H.3
Miyao, T.4
Shimazaki, T.5
Ishii, K.6
-
36
-
-
33845603466
-
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation
-
Palazuelos J, Aguado T, Egia A, Mechoulam R, Guzman M, Galve-Roperh I. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. FASEB J 2006; 20: 24057.
-
(2006)
FASEB J
, vol.20
, pp. 24057
-
-
Palazuelos, J.1
Aguado, T.2
Egia, A.3
Mechoulam, R.4
Guzman, M.5
Galve-Roperh, I.6
-
37
-
-
45149123400
-
The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: Involvement in the pathogenesis of an animal model of multiple sclerosis
-
Palazuelos J, Davoust N, Julien B, Hatterer E, Aguado T, Mechoulam R, et al. The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis. J Biol Chem 2008; 283: 133209.
-
(2008)
J Biol Chem
, Issue.283
, pp. 133209
-
-
Palazuelos, J.1
Davoust, N.2
Julien, B.3
Hatterer, E.4
Aguado, T.5
Mechoulam, R.6
-
38
-
-
33749512169
-
The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum
-
Pintor A, Tebano MT, Martire A, Grieco R, Galluzzo M, Scattoni ML, et al. The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum. Neuropharmacology 2006; 51: 100412.
-
(2006)
Neuropharmacology
, vol.51
, pp. 100412
-
-
Pintor, A.1
Tebano, M.T.2
Martire, A.3
Grieco, R.4
Galluzzo, M.5
Scattoni, M.L.6
-
39
-
-
0242304878
-
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
-
Pryce G, Ahmed Z, Hankey DJ, Jackson SJ, Croxford JL, Pocock JM, et al. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 2003; 126: 2191202.
-
(2003)
Brain
, vol.126
, pp. 2191202
-
-
Pryce, G.1
Ahmed, Z.2
Hankey, D.J.3
Jackson, S.J.4
Croxford, J.L.5
Pocock, J.M.6
-
40
-
-
14244264502
-
Prevention of Alzheimer's disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation
-
Ramirez BG, Blazquez C, Gomez del Pulgar T, Guzman M, de Ceballos ML. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 2005; 25: 190413.
-
(2005)
J Neurosci
, vol.25
, pp. 190413
-
-
Ramirez, B.G.1
Blazquez, C.2
Gomez Del Pulgar, T.3
Guzman, M.4
De Ceballos, M.L.5
-
41
-
-
0028071467
-
Selective vulnerability in Huntington's disease: Preferential loss of cannabinoid receptors in lateral globus pallidus
-
Richfield EK, Herkenham M. Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Ann Neurol 1994; 36: 57784.
-
(1994)
Ann Neurol
, vol.36
, pp. 57784
-
-
Richfield, E.K.1
Herkenham, M.2
-
42
-
-
67649885952
-
Cannabinoid CB(2) receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease
-
Sagredo O, Gonzalez S, Aroyo I, Pazos MR, Benito C, Lastres-Becker I, et al. Cannabinoid CB(2) receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease. Glia 2008; 57: 115467.
-
(2008)
Glia
, vol.57
, pp. 115467
-
-
Sagredo, O.1
Gonzalez, S.2
Aroyo, I.3
Pazos, M.R.4
Benito, C.5
Lastres-Becker, I.6
Al, E.7
-
43
-
-
0035111235
-
Early and progressive accumulation of reactive microglia in the Huntington disease brain
-
Sapp E, Kegel KB, Aronin N, Hashikawa T, Uchiyama Y, Tohyama K, et al. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol 2001; 60: 16172.
-
(2001)
J Neuropathol Exp Neurol
, vol.60
, pp. 16172
-
-
Sapp, E.1
Kegel, K.B.2
Aronin, N.3
Hashikawa, T.4
Uchiyama, Y.5
Tohyama, K.6
-
44
-
-
29144460321
-
Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
-
Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 2005; 171: 100112.
-
(2005)
J Cell Biol
, vol.171
, pp. 100112
-
-
Shin, J.Y.1
Fang, Z.H.2
Yu, Z.X.3
Wang, C.E.4
Li, S.H.5
Li, X.J.6
-
45
-
-
33947278309
-
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset
-
Shoemaker JL, Seely KA, Reed RL, Crow JP, Prather PL. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. J Neurochem 2007; 101: 8798.
-
(2007)
J Neurochem
, vol.101
, pp. 8798
-
-
Shoemaker, J.L.1
Seely, K.A.2
Reed, R.L.3
Crow, J.P.4
Prather, P.L.5
-
46
-
-
34447520021
-
Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease
-
Simmons DA, Casale M, Alcon B, Pham N, Narayan N, Lynch G. Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease. Glia 2007; 55: 107484.
-
(2007)
Glia
, vol.55
, pp. 107484
-
-
Simmons, D.A.1
Casale, M.2
Alcon, B.3
Pham, N.4
Narayan, N.5
Lynch, G.6
-
47
-
-
34447636065
-
Microglial activation in presymptomatic Huntington's disease gene carriers
-
Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, et al. Microglial activation in presymptomatic Huntington's disease gene carriers. Brain 2007; 130: 175966.
-
(2007)
Brain
, vol.130
, pp. 175966
-
-
Tai, Y.F.1
Pavese, N.2
Gerhard, A.3
Tabrizi, S.J.4
Barker, R.A.5
Brooks, D.J.6
-
48
-
-
0041335559
-
Minocycline inhibits caspase-independent and-dependent mito-chondrial cell death pathways in models of Huntington's disease
-
Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, et al. Minocycline inhibits caspase-independent and-dependent mito-chondrial cell death pathways in models of Huntington's disease. Proc Natl Acad Sci USA 2003; 100: 104837.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 104837
-
-
Wang, X.1
Zhu, S.2
Drozda, M.3
Zhang, W.4
Stavrovskaya, I.G.5
Cattaneo, E.6
-
49
-
-
39749188753
-
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
-
Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 2008; 11: 251-3.
-
(2008)
Nat Neurosci
, vol.11
, pp. 251-3
-
-
Yamanaka, K.1
Chun, S.J.2
Boillee, S.3
Fujimori-Tonou, N.4
Yamashita, H.5
Gutmann, D.H.6
|